This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovations of Sarah E. Gilpin
Introduction
Sarah E. Gilpin is a prominent inventor based in Somerville, MA, known for her groundbreaking work in lung epithelial engineering. She has made significant contributions to the field of regenerative medicine, particularly through her innovative use of human airway stem cells.
Latest Patents
Sarah holds a patent for "Human airway stem cells in lung epithelial engineering." This patent outlines methods of using human airway stem cells in lung epithelial engineering, including the potential application of gamma secretase inhibitors. Additionally, it discusses the production of bioartificial airway organs and their use in transplantation. The patent also covers methods for treating a bio-artificial matrix with Tenascin-C and/or fibrillin 2.
Career Highlights
Sarah is affiliated with The General Hospital Corporation, where she continues to advance her research and innovations. Her work has garnered attention for its potential to revolutionize treatments for lung-related diseases.
Collaborations
Sarah collaborates with notable professionals in her field, including her coworker Harald C. Ott, enhancing the impact of her research through shared expertise and knowledge.
Conclusion
Sarah E. Gilpin's contributions to lung epithelial engineering exemplify the power of innovation in medicine. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.